Company Info
Phone(650) 260-7120
Year Established
2007
Ticker
IOVA
Exchange
NASDAQ
Contacts
Frederick G. Vogt, PhD, Esq.Interim CEO, President & General Counsel
Igor Bilinsky
COO
Howard B. Johnson, M.B.A.
CBO
Company Description
Iovance Biotherapeutics, Lion Biotechnologies, is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL).
